Evaluaton of therapy with cabergoline in men with macroprolactinoa.doi:10.21164/POMJLIFESCI.95Elzbieta Andrysiak-MamosAgnieszka Kamierczyk-PuchalskaEwa ZochowskaElzbieta Sowińska-PrzepieraLeszek SaganIreneusz KojderAnhelli SyreniczPomeranian J Life Sci...
, nausea, and hypotension.68,69InParkinson's disease, patients are treated with a higher dose of cabergoline and adverse effects such asvalvular heart diseasehave been well documented.74Although lower doses are used in Cushing's disease, serialechocardiographyhas been advised in long-term use....
The effect of this medicine during pregnancy is poorly known: only your doctor can evaluate the possible risk of its use in your case. Breastfeeding: This medicine blocks lactation. Hyperprolactinemia results in variable symptoms: absence of menstruation, disorders of the cycle, infertility in women...
Prolactin suppression to below 3 x ULN was achieved in 34 (94%; mean weekly cabergoline dose of 1.2 mg), 37 (90%; cabergoline dose, 2.1 mg), and 15 (88%; cabergoline dose, 2.8 mg) men (P = 0.31) in each group. After excluding patients that underwent surgery and radiotherapy, ...
Due to the low incidence of male microprolactinoma, there is a paucity of data in the literature regarding its management. Our aim was to investigate the long-term outcomes of cabergoline treatment in men with microprolactinoma.In this single-center retrospective cohort study, we reviewed patient'...
Corsello SM, Ubertini G, Altomare M, Lovicu RM, Migneco MG, Rota CA, Colosimo C (2003) Giant Prolactinomas in men: efficacy of cabergoline treatment. Clin Endocrinol 58:662-670Corsello SM,,Ubertini G,Altomare M,et al.Giant prolactinomas in men:efficacy of CAB treatment.Clinical ...
Cabergoline effective for prolactinoma in menNo Abstract available for this article.doi:10.2165/00128413-200414400-00028NoneSpringer International PublishingInpharma Weekly
(2010) Cabergoline-Induced Cerebral Spinal Fluid Leak in a Patient With a Large Prolactinoma and MEN1. The Endocrinologist 20 , 198-202 Online publication date: 1-Jul-2010. /Chapin W, Yedinak CG, Delashaw JB Jr, Fleseriu M (2010) Cabergoline-induced cerebral spinal fluid leak ...
AkiraShimatsuBMJ case reportsNanba K et al. (2013). Tension pneumocephalus after administration of two 0.25 mg cabergoline tablets in MEN1-related Macroprolactinoma. BMJ Case Rep. 2013.Nanba K, et al. Tension pneumocephalus after administration of two 0.25 mg cabergoline tablets in MEN1-related...
therapy of hyperprolatinemia, while known to activate the 5HT2B receptor, was not proven to cause cardiac risk until 2007, when two studies in the New England Journal of Medicine (NEJM) reported that dopamine agonists were associated with valvular regurgitation in men treated for Parkinson's . ...